Metabolomic profiling reveals distinct patterns of tricarboxylic acid disorders in blood stasis syndrome associated with coronary heart disease

Yong Wang; Chun Li; Hong Chang; Ling-hui Lu; Qi Qiu; Yu-lin Ouyang; Jun-da Yu; Shu-zhen Guo; Jing Han; Wei Wang

doi:10.1007/s11655-015-2401-1

Your Location：

Home >

Browse articles >

Metabolomic profiling reveals distinct patterns of tricarboxylic acid disorders in blood stasis syndrome associated with coronary heart disease

OriginalPaper | Updated：2021-08-27

- Metabolomic profiling reveals distinct patterns of tricarboxylic acid disorders in blood stasis syndrome associated with coronary heart disease
- Metabolomic profiling reveals distinct patterns of tricarboxylic acid disorders in blood stasis syndrome associated with coronary heart disease
- 中国结合医学杂志（英文版） 2016年22卷第8期页码：597-604
- Affiliations：
  
  1. Precilincal School, Beijing University of Chinese Medicine,Beijing,China
  2. Modern Research Center for Traditional Chinese Medicine, Beijing University of Chinese Medicine,Beijing,China
  3. Capital Medical University Beijing Anzhen Hospital,Beijing,China
  4. Southern Illinois University School of Medicine,Springfield,USA
- Author bio：
- Funds：
  
  Supported by the National Natural Science Foundation of China (Nos. 81202788, 81473456, 81470191 and 81302908), the National Science and Technology Pillar Program (No. 2012BAI29B07), Beijing Natural Science Foundation (No. 7142099), and Excellent Young Scientist Foundation of Beijing University of Chinese Medicine (No. 2015-JYB-XYQ001)
- DOI：10.1007/s11655-015-2401-1
  中图分类号：
- 纸质出版日期：2016，
  
  网络出版日期：2016-5-16，
Scan for full text
Wang, Y., Li, C., Chang, H. et al. Metabolomic profiling reveals distinct patterns of tricarboxylic acid disorders in blood stasis syndrome associated with coronary heart disease., Chin. J. Integr. Med. 22, 597–604 (2016). https://doi.org/10.1007/s11655-015-2401-1

Yong Wang, Chun Li, Hong Chang, et al. Metabolomic profiling reveals distinct patterns of tricarboxylic acid disorders in blood stasis syndrome associated with coronary heart disease[J]. Chinese Journal of Integrative Medicine, 2016,22(8):597-604.
Wang, Y., Li, C., Chang, H. et al. Metabolomic profiling reveals distinct patterns of tricarboxylic acid disorders in blood stasis syndrome associated with coronary heart disease., Chin. J. Integr. Med. 22, 597–604 (2016). https://doi.org/10.1007/s11655-015-2401-1 DOI：

Yong Wang, Chun Li, Hong Chang, et al. Metabolomic profiling reveals distinct patterns of tricarboxylic acid disorders in blood stasis syndrome associated with coronary heart disease[J]. Chinese Journal of Integrative Medicine, 2016,22(8):597-604. DOI： 10.1007/s11655-015-2401-1.

摘要

To investigate the underlying metabolomic profifiling of coronary heart disease (CHD) with blood stasis syndrome (BSS). CHD model was induced by a nameroid constrictor in Chinese miniature swine. Fifteen miniature swine were randomly divided into a model group (n=9) and a control group (n=6)

respectively according to arandom number table. After 4 weeks

plasma hemorheology was detected by automatic hemorheological analyzer

indices including hematocrit

plasma viscosity

blood viscosity

rigidity index and erythrocyte sedimentation rate; cardiac function was assessed by echocardiograph to detect left ventricular end-systolic diameter (LVED)

left ventricular end-diastolic diameter (LVEDd)

ejection fraction (EF)

fractional shortening (FS) and other indicators. Gas chromatography coupled with mass spectrometry (GC-MS) and bioinformatics were applied to analyze spectra of CHD plasma with BSS. The results of hemorheology analysis showed signifificant changes in viscosity

with low shear whole blood viscosity being lower and plasma viscosity higher in the model group compared with the control group. Moreover

whole blood reduction viscosity at high shear rate and whole blood reduction viscosity at low shear rate increased signifificantly (P <0.05). The echocardiograph results demonstrated that cardiac EF and FS showed signifificant difference (P <0.05)

with EF values being decreased to 50% or less. The GC-MS data showed that principal component analysis can clearly separate the animals with BSS from those in the control group. The enriched Kyoto Encyclopedia of Genes and Genomes biological pathways results suggested that the patterns involved were associated with dysfunction of energy metabolism including glucose and lipid disorders

especially in glycolysis/gluconeogenesis

galactose metabolism and adenosine-triphosphate-binding cassette transporters. Glucose metabolism and lipid metabolism disorders were the major contributors to the syndrome classifification of CHD with BSS.

Abstract

respectively according to arandom number table. After 4 weeks

plasma hemorheology was detected by automatic hemorheological analyzer

indices including hematocrit

plasma viscosity

blood viscosity

rigidity index and erythrocyte sedimentation rate; cardiac function was assessed by echocardiograph to detect left ventricular end-systolic diameter (LVED)

left ventricular end-diastolic diameter (LVEDd)

ejection fraction (EF)

with low shear whole blood viscosity being lower and plasma viscosity higher in the model group compared with the control group. Moreover

especially in glycolysis/gluconeogenesis

关键词

metabolomic profilingBlood Stasis Syndromecoronary heart diseaseChinese Medicine

Keywords

metabolomic profilingBlood Stasis Syndromecoronary heart diseaseChinese Medicine

references

He J, Gu D, Wu X, Reynolds K, Duan X, Yao C, et al. Major causes of death among men and women in China. N Engl J Med 2005;353:1124–1134.

Wang J, Chen KJ, Weng WL, Qian ZH, Wang Y, Liu JG, et al. Research on diagnostic criteria of blood-stasis symptomcomplex. Chin J Integr Tradit West Med (Chin) 1988;8:585–589.

Miao Y, Zhao WJ, Jing L. Retrospective analysis on integrative medicinal treatment of chronic heart failure. Chin J Integr Tradit West Med (Chin) 2008;28:406–409.

Wang J, Chu FY, Li J, Yao KW, Zhong JB, Zhou KH, et al. Study on Syndrome element characteristics and its correlation with coronaryangiography in 324 patients with coronary heart disease. J Chin Integr Med (Chin) 2008;14:274–280.

Wu HL, Ruan XM, Yang XB. Analysis on TCM syndrome distribution laws in 319 patients with coronary heart disease. Chin J Integr Tradit West Med (Chin) 2007;27:2498–2500.

Nicholson JK, Wilson ID. Opinion: understanding ‘global’ systems biology: metabonomics and the continuum of metabolism. Nat Rev Drug Discov 2003;2:668–676.

Simón-Manso Y, Lowenthal MS, Kilpatrick LE, Sampson ML, Telu KH, Rudnick PA, et al. Metabolite profiling of a NIST standard reference material for human plasma (SRM 1950): GC-MS, LC-MS, NMR, and clinical laboratory analyses, libraries, and web-based resources. Anal Chem 2013;85:11725–11731.

Nicholson JK, Connelly J, Lindon JC. Holmes E. Metabonomics: a platform for studying drug toxicity and gene function. Nat Rev Drug Discov 2002;1:153–161.

Fiehn O, Kopka J, Dormann P, Altmann T, Trethewey RN, Willmitzer L. Metabolite profiling for plant functional genomics. Nat Biotechnol 2000;18:1157–1161.

Danielsson AP, Moritz T, Mulder H, Spegel P. Development and optimization of a metabolomic method for analysis of adherent cell cultures. Anal Biochem 2010;404:30–39.

Griffin JL. The Cinderella story of metabolic profiling: does metabolomics get to go to the functional genomics ball? Phil Trans R Soc B 2006;361:147–161.

Klocke R, Tian W, Kuhlmann MT, Nikol S. Surgical animal models of heart failure related to coronary heart disease. Cardiovasc Res 2007;74:29–38.

Voisine P, Bianchi C, Ruel M, Malik T, Rosinberg A, Feng J, et al. Inhibition of the cardiac angiogenic response to exogenous vascular endothelial growth factor. Surgery 2004;136:407–415.

Wang J, Abraham TP, Korinek J, Urheim S, McMahon EM, Belohlavek M. Delayed onset of subendocardial diastolic thinning at rest identifies hypoperfused myocardium. Circulation 2005;111:2943–2450.

Tuzun E, Oliveira E, Narin C, Khalil H, Jimenez-Quevedo P, Perin E, et al. Correlation of ischemia Area and coronary flow with ameroid size in a porcine Model. J Surgic Res 2010;164:38–42.

Wang Y, Li C, Chuo WJ, Yu Ju, Guo SZ, Wang W. Establishment and evaluation on miniature pig model of ischemic coronary heart disease with qi deficiency and blood stasis syndrome. Chin J Integr Med 2011;31:233–237.

Qiu Q, Guo SZ, Chen JX, Zhao HH, Liu L, Chen C, et al. Literature research of coronary heart disease syndromes associated physical and chemical indexes based on Shannon entropy mutual information. Chin J Tradit Chin Med Pharm (Chin) 2009;24:1284–1287.

Xue M, Chen KJ, Ma XJ, Liu JG, Jiang YR, Miao Y, et al. Effects of Xuefu Zhuyu Oral Liquid on hemorheology in patients with blood-stasis syndrome due to coronary disease and their relationship with human platelet antigen-3 polymorphism. J Chin Integr Med (Chin) 2008;6:1129–1135.

Wishart DS. Current progress in computational metabolomics. Brief Bioinform 2007;8:279–293.

Wang Y, Chuo WJ, Guo SZ, Li C, Wang W. Proteomics of blood stasis syndrome based on myocardial ischemiamodel of coronary heart disease in min-swines. J Beijing Univ Tradit Chin Med (Chin) 2011;34:460–464.

Sasso FC, Carbonara O, Nasti R, Campana B, Marfella R, Torella M, et al. Glucose metabolism and coronary heart disease in patients with normal glucose yolerance. JAMA 2004;291:1857–1863.

Demir O, Aksan Kurnaz I. An integrated model of glucose and galactose metabolism regulated by the GAL genetic switch. Comput Biol Chem 2006;30:179–192.

Fitzgerald ML, Mujawar Z, Tamehiro N. ABC transporters, atherosclerosis and inflammation. Atherosclerosis 2010;211:361–370.

RG Schwartz, EJ Barrett, CK Francis, R Jacob, BL Zaret. Regulation of myocardial amino acid balance in the conscious dog. J Clin Invest 1985;75:1204–1211.

Sabatine M S, Liu E, Morrow DA, Heller E, McCarroll R, Wiegand R, et al. Metabolomic identification of novel biomarkers of myocardialischemia. Circulation 2005;112:3868–3875.

FULL TEXT LINK

More>

浏览量

Downloads

CSCD

文章被引用时，请邮件提醒。

Submit

工具集

关联资源

Association of platelet-activating factor receptor gene rs5938 (G/T) and rs313152 (T/C) polymorphisms with coronary heart disease and blood stasis syndrome in a Chinese Han population

Blood stasis syndrome of coronary heart disease: A perspective of modern medicine

Biomedical mechanisms of blood stasis syndrome of coronary heart disease by systems biology approaches

Research on the correlation between platelet gelsolin and blood-stasis syndrome of coronary heart disease